样式: 排序: IF: - GO 导出 标记为已读
-
Considering gestational age in the biologic response of the fetus to cytomegalovirus Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-06-22 Léo Pomar PhD, Milos Stojanov PhD, David Baud MD PhD
-
Optimal dosing of antenatal corticosteroids: are we doing it right? Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-06-21 Mahima Rajan MD, Supreet Khurana DM
-
Collider bias in a secondary analysis of the antenatal late preterm steroids trial Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-06-21 Isabelle Dehaene MD PhD, Kristien Roelens MD PhD, Koenraad Smets MD PhD
-
A low maternal mortality ratio requires an effective health system that values women Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-06-20 Binod Bindu Sharma PhD, Craig Pennell MD PhD, Biraj Sharma MB BS, Roger Smith MB BS (Hons) PhD
-
Randomized controlled trial of twin-twin transfusion syndrome laser surgery: the sequential trial Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-06-17 Ramen H. Chmait MD, Lisa M. Korst MD PhD, Arlyn S. Llanes RN, Kristine R. Rallo RN, Andrew H. Chon MD, Martha A. Monson MD, Moshe Fridman PhD, Rubén A. Quintero MD
Intraoperative blood transfer between twins during laser surgery for twin-twin transfusion syndrome can vary by surgical technique and has been proposed to explain differences in donor twin survival. This trial compared donor twin survival with 2 laser techniques: the sequential technique, in which the arteriovenous communications from the volume-depleted donor to the volume-overloaded recipient are
-
A pilot randomized trial of automatic, artificial intelligence-based vs manual, electronic medical record-based remote postpartum blood pressure monitoring Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-06-14 Adam K. Lewkowitz MD MPHS, Rackeem Baker BA, Lauren E. Schlichting PhD, Crystal F. Ware BSN CCRP, Janet Rousseau BSN, Emily S. Miller MD MPH, Alisse Hauspurg MD MS, Dwight J. Rouse MD, Caroline Richardson MD, Roee Gutman PhD, Methodius G. Tuuli MD MPH
-
Physician preparation for the American Board of Obstetrics and Gynecology qualifying examination Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-06-14 Pooja Shivraj MS PhD, Heath Kincaid BS, Rajat Chadha PhD, Anthony Sparks PhD, George D. Wendel Jr. MD
-
Improving early detection of preeclampsia in prenatal care through predictive modeling Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-06-13 Keyan Jin
-
Cornual or interstitial ectopic pregnancy? Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-06-11 Mariam Obaid MD, Mohannad Abu-Faza MD, Ibrahim A. Abdelazim MD
-
The relation between low-grade fever during prolonged rupture of membranes (>12 hours) at term and infectious outcomes: a retrospective cohort study Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-06-11 Raneen Abu Shqara MD, Yara Nakhleh Francis MD, Lior Lowenstein MD, Maya Frank Wolf MD
Intrapartum fever (>38°C) is associated with adverse maternal and neonatal outcomes. However, the correlation between low-grade fever (37.5°C–37.9°C) and adverse perinatal outcomes remains controversial. This study aimed to compare maternal and neonatal outcomes of women with prolonged rupture of membranes (≥12 hours) at term between those with low-grade fever and those with normal body temperature
-
Induction of labor vs expectant management among low-risk patients with 1 prior cesarean delivery Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-06-07 Erinma P. Ukoha MD MPH, Timothy Wen MD MPH, Uma M. Reddy MD MPH
Studies that have compared induction of labor in individuals with 1 prior cesarean delivery to expectant management have shown conflicting results. To determine the association between clinical outcomes and induction of labor at 39 weeks in a national sample of otherwise low-risk patients with 1 prior cesarean delivery. This cross-sectional study analyzed 2016 to 2021 US Vital Statistics birth certificate
-
Multiethnic growth standards for fetal body composition and organ volumes derived from 3D ultrasonography Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-06-03 Katherine L. Grantz MD, Wesley Lee MD, Lauren M. Mack MPH RDMS, Magdalena Sanz Cortes MD, Luis F. Goncalves MD, Jimmy Espinoza MD, Roger B. Newman MD, William A. Grobman MD, Ronald J. Wapner MD, Karin Fuchs MD, Mary E. D'Alton MD, Daniel W. Skupski MD, John Owen MD, Anthony Sciscione DO, Deborah A. Wing MD, Michael P. Nageotte MD, Angela C. Ranzini MD, Edward K. Chien MD, Sabrina Craigo MD, Seth Sherman
A major goal of contemporary obstetrical practice is to optimize fetal growth and development throughout pregnancy. To date, fetal growth during prenatal care is assessed by performing ultrasonographic measurement of 2-dimensional fetal biometry to calculate an estimated fetal weight. Our group previously established 2-dimensional fetal growth standards using sonographic data from a large cohort with
-
Altered extracellular matrix–related pathways accelerate the transition from normal to prefibroid myometrium in Black women Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-31 Maria Victoria Bariani PhD, Sandra L. Grimm PhD, Cristian Coarfa PhD, Digna R. Velez Edwards PhD, Qiwei Yang PhD, Cheryl L. Walker PhD, Mohamed Ali PhD, Ayman Al-Hendy MD PhD
Black women experience a disproportionate impact of uterine fibroids compared to White women, including earlier diagnosis, higher frequency, and more severe symptoms. The etiology underlying this racial disparity remains elusive. The aim of this study was to evaluate the molecular differences in normal myometrium (fibroid-free uteri) and at-risk myometrium (fibroid-containing uteri) tissues in Black
-
Plasma soluble fms-like tyrosine kinase 1 to placental growth factor ratio of 11.5 multiples of median predicts preeclampsia with severe features within 2 weeks of testing Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-31 Jimmy Espinoza MD MSc, Vinicius F. Calsavara PhD, Sarah Kilpatrick MD PhD, Sarosh Rana MD MPH, Maged M. Costantine MD, Kim Boggess MD, Blair J. Wylie MD MPH, Tiffany A. Moore Simas MD MPH MEd, Judette M. Louis MD MPH, Stephanie L. Gaw MD PhD, Amy Murtha MD, Samantha Wiegand MD, Yvonne Gollin MD, Deepjot Singh MD MMM, Robert M. Silver MD, Danielle E. Durie MD MPH, Britta Panda MD, Errol R. Norwitz MD
Angiogenic imbalances, characterized by an excess of antiangiogenic factors (soluble fms-like tyrosine kinase 1) and reduced angiogenic factors (vascular endothelial growth factor and placental growth factor), contribute to the mechanisms of disease in preeclampsia. The ratio of soluble fms-like tyrosine kinase 1 to placental growth factor has been used as a biomarker for preeclampsia, but the cutoff
-
A hidden crisis: postpartum readmissions for mental health and substance use disorders in rural and racial minority communities Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-25 Peiyin Hung PhD, Jiajia Zhang PhD, Shujie Chen PhD, Sayward E. Harrison PhD, Nansi S. Boghossian PhD, Xiaoming Li PhD
-
A bundle of opioid-sparing strategies to eliminate routine opioid prescribing in a urogynecology practice Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-25 Jessica M. Selle DO, Danielle M. Strozza MD, Megan E. Branda MS, John B. Gebhart MD MS, Emanuel C. Trabuco MD MS, John A. Occhino MD MS, Brian J. Linder MD MS, Sherif A. El Nashar MD MS, Annetta M. Madsen MD
Current evidence supports that many patients do not use prescribed opioids following reconstructive pelvic surgery, yet it remains unclear if it is feasible to eliminate routine opioid prescriptions without a negative impact on patients or providers. To determine if there is a difference in the proportion of patients discharged without opioids after implementing a bundle of opioid-sparing strategies
-
Changes and challenges in the residency application process in obstetrics and gynecology Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-25 Katherine T. Chen MD MPH, Celeste S. Royce MD, Laura Baecher-Lind MD MPH, Rashmi Bhargava MD, Angela Fleming DO, Helen Kang Morgan MD, Christopher M. Morosky MD, Jonathan A. Schaffir MD, Shireen Madani Sims MD, Tammy Sonn MD, Jill M. Sutton MD, Alyssa Stephenson-Famy MD, Undergraduate Medicine Education Committee, Association of Professors of Gynecology and Obstetrics
Faculty career advisors who guide applicants applying to obstetrics and gynecology residency programs need updated information and resources, given the constant changes and challenges to the residency application process. Initial changes included standardization of the application timeline and interview processes. More recent changes included the utilization of a standardized letter of evaluation,
-
Preterm birth in singleton pregnancies conceived by in vitro fertilization or intracytoplasmic sperm injection: an overview of systematic reviews Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-23 Noemi Salmeri MD, Alessandra Alteri PhD, Antonio Farina MD, Mirko Pozzoni MD, Paola Vigano’ PhD, Massimo Candiani MD, Paolo Ivo Cavoretto MD
The rate of preterm birth of singletons conceived through in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) is increased, being as high as 15% to 16% across Europe and the United States. However, the underlying etiology, phenotype, and mechanisms initiating preterm birth (PTB) are poorly understood. To quantify the PTB risk and examine supposed etiology in IVF/ICSI singleton pregnancies
-
Prepregnancy physiology and subsequent preterm preeclampsia Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-23 Ira M. Bernstein MD, Gary J. Badger MS, Carole A. McBride PhD
Preeclampsia is a common pregnancy complication with debated etiology. To evaluate the contribution of prepregnancy physiology, biochemistry, and anthropometrics to the subsequent development of preterm preeclampsia. One hundred twenty-four participants were recruited through open recruitment and targeted mailings. Participants included 81 nulliparous women and 43 with a history of preterm preeclampsia
-
Stillbirth: we can do better Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-23 Robert M. Silver MD, Uma Reddy MD
Stillbirth is far too common, occurring in millions of pregnancies per year globally. The rate of stillbirth (defined as death of a fetus prior to birth at 20 weeks' gestation or more) in the United States is 5.73 per 1000. This is approximately 1 in 175 pregnancies accounting for about 21,000 stillbirths per year. Although rates are much higher in low-income countries, the stillbirth rate in the United
-
Mepivacaine instillation for pain reduction during intrauterine device placement in nulliparous women: a double-blinded randomized trial Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-23 Niklas Envall RNM PhD, Karin Elgemark MD, Helena Kopp Kallner MD PhD
Fear of pain associated with intrauterine device (IUD) placement has been identified as a significant barrier to the adoption of long-acting reversible contraception, contributing to lower utilization of the most effective reversible contraceptive methods. To assess whether instillation of intrauterine mepivacaine before IUD placement alleviates pain more effectively than a placebo. We conducted a
-
A multisite study to develop and validate first trimester, circulating microparticle biomarkers for tiered risk stratification of spontaneous preterm birth in nulliparas Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-23 Kevin P. Rosenblatt MD PhD, Zhen Zhang PhD, Robert Doss PhD, Prem P. Gurnani MS, William A. Grobman MD MBA, Robert M. Silver MD, Samuel Parry MD, Uma M. Reddy MD MPH, Sha Cao PhD, David M. Haas MD MS
Despite much research, advances in early prediction of spontaneous preterm birth (sPTB) has been slow. The evolving field of circulating microparticle (CMP) biology may identify novel blood-based, and clinically useful, biomarkers. To test the ability of a previously identified, 7-marker set of CMP-derived proteins from the first trimester of pregnancy, in the form of an in vitro diagnostic multivariate
-
Placement of an intrauterine device within 48 hours after second-trimester medical abortion: a randomized controlled trial Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-23 Sara Hogmark MD PhD, Johanna Rydelius MD, Niklas Envall RNM PhD, Pia Teleman MD PhD, Kristina Gemzell-Danielsson MD PhD, Helena Kopp Kallner MD PhD
International guidelines recommend placement of intrauterine devices immediately after second-trimester medical abortion, but evidence concerning the optimal time for intrauterine device placement is lacking from clinical trials. This study aimed to investigate effectiveness, safety, and acceptability of intrauterine device placement within 48 hours, compared with placement at 2 to 4 weeks after second-trimester
-
Using the term “obstetric violence” in a broad and unsuitable manner introduces an unfortunate ambiguity Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-23 Amos Grünebaum MD, Frank A. Chervenak MD
-
Let us name—and shame—obstetric violence Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-23 Andrea Bidoli MSc
-
Terminology: obstetric violence Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-23 Tatiana Henriques Leite PhD, Marília Arndt Mesenburg PhD, Emanuele Souza Marques PhD
-
Prenatal methamphetamine use increases risk of adverse maternal and neonatal outcomes Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-22 Sarena Hayer MD MA MSc, Bharti Garg MBBS MPH, Jessica Wallace MD, Kristin C. Prewitt MD MPH, Jamie O. Lo MD MCR, Aaron B. Caughey MD PhD
Although methamphetamine use has been increasing in recent years and occurring within new populations and in broader geographical areas, there is limited research on its use and effect in pregnancy. This study aimed to examine the association between prenatal methamphetamine use and maternal and neonatal outcomes in a large, contemporary birth cohort. This was a retrospective cohort study using California-linked
-
Assisted reproductive technology and neurodevelopment in children at 1 year of age: a longitudinal birth cohort study Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-22 Weiting Wang MPH, Qingxia Meng MD, Lingmin Hu MD PhD, Jiangbo Du PhD, Bo Xu MPH, Xiumei Han MPH, Xiaoyu Liu MPH, Kun Zhou MPH, Kang Ke PhD, Ming Gan MPH, Xianxian Zhu MPH, Yuting Peng MPH, Huixin Xue MPH, Shuxin Xiao MPH, Hong Lv PhD, Yangqian Jiang PhD, Tao Jiang PhD, Hongxia Ma MD PhD, Xiufeng Ling MD PhD, Zhibin Hu MD PhD, Yuan Lin MD PhD
With remarkable advancements in assisted reproductive technology (ART), the number of ART-conceived children continues to increase. Despite increased research investigating the outcomes of ART children, evidence on neurodevelopment remains controversial. The aim of this study was to investigate the association between ART use and neurodevelopment in children at 1 year of age and to determine whether
-
Wrongful birth and wrongful life lawsuits in obstetrics and gynecology Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-22 Christopher P. Moutos MD, John Y. Phelps MD JD
Developments in preconception and prenatal technologies have led to undeniable advances in how health-care providers screen and treat patients. Despite these advances, at any point errors can occur leading to misdiagnosis or a missed diagnosis. In some instances, the missed information can lead to the birth of a child with health issues where short of the error, the decision to avoid conception or
-
Mechanisms of pain and retrograde menstruation in endometriosis Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-21 M.J. Quinn MD LLM
-
Associations between endometriosis and common symptoms Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-21 Dereje G. Gete PhD, Gita D. Mishra PhD
-
Treatment of intrauterine adhesions and subsequent pregnancy outcomes in an in vitro fertilization population Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-20 Roisin M. Mortimer MBBCH BAO, Andrea Lanes PhD, Serene S. Srouji MD, Ian Waldman MD, Elizabeth Ginsburg MD
Asherman syndrome refers to the presence of intrauterine adhesions, which have clinical implications, including infertility. There are few studies assessing the effect of serial hysteroscopies for adhesiolysis on reproductive and pregnancy outcomes among women who subsequently undergo in vitro fertilization, and none have looked at maternal, neonatal, or placental pregnancy complications. This study
-
Medication and procedural abortions before 13 weeks gestation and risk of psychiatric disorders Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-20 Julia R. Steinberg PhD, Thomas M. Laursen PhD, Øjvind Lidegaard MD DMSc, Trine Munk-Olsen PhD
The proportion of abortions provided by medication in the United States and worldwide has increased greatly since the U.S. Food and Drug Administration approved mifepristone in 2000. While existing research has shown that abortion does not increase risk of mental health problems, no population-based study has examined specifically whether a procedural or medication abortion increases risk of mental
-
Society for Maternal-Fetal Medicine Position Statement: Paid family and medical leave Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-20 Society for Maternal-Fetal Medicine (SMFM), SMFM Health Policy and Advocacy Committee
-
Gestational carrier cycles: embryology trends, national guideline compliance, and resultant perinatal outcomes in the United States, 2014–2020 Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-20 Ariana M. Traub MPH, Lisa M. Shandley MD MSCR, Heather S. Hipp MD, Jennifer F. Kawwass MD
The increased use of gestational carriers has expanded family-building opportunities for people and couples unable to carry pregnancies on their own. National American Society of Reproductive Medicine guidelines for gestational carriers have changed over time to reflect advances in reproductive technology and mounting evidence supporting the medical benefits associated with singleton gestations. Assess
-
Bladder instillations vs onabotulinumtoxinA injection for interstitial cystitis/bladder pain syndrome: a randomized clinical trial Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-18 Eva K. Welch MD MS, Katherine L. Dengler MD, Angela M. DiCarlo-Meacham MD, Joy E. Wheat MD, Carissa J. Pekny MD, James K. Aden PhD, Christine M. Vaccaro DO
Interstitial cystitis (IC)/bladder pain syndrome (BPS) is an unpleasant sensation related to the bladder with lower urinary tract symptoms lasting more than 6 weeks, unrelated to an otherwise identifiable cause. The etiology is likely multifactorial including urothelial abnormalities, neurogenic pain upregulation, and potentially bladder and vaginal microbiome alterations. Despite treatment effectiveness
-
Consumer wearables and personal devices for tracking the fertile window Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-18 Sarah C. Cromack MD, Jessica R. Walter MD MSCE
The market for technology that tracks ovulation to promote conception is rapidly expanding in the United States, targeting the growing audience of technologically proficient, reproductive-age female consumers. In this narrative review, 23 different, nonprescription wearables and devices designed to help women track their fertile window were identified as currently, commercially available in the United
-
A potential path toward standardized radical hysterectomy Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-17 Yinluan OuYang MD, Xiaofeng Zhao MD PhD
-
Role of English proficiency in health equity divisions in departments of obstetrics and gynecology Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-17 Camille A. Clare MD MPH, Christina Pardo MD MPH, Howard Minkoff MD
-
Divisions of health equity in departments of obstetrics and gynecology: English proficiency Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-17 Virginia Vasquez-Rios MD BS, Dmitry Tumin PhD
-
Guiding principles of classification of radical hysterectomies Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-17 Denis Querleu MD, Nicolò Bizzarri MD, Giovanni Scambia MD
-
Ileal perforation caused by intrauterine device displacement Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-17 Liyi Zhang MD, Yucheng Lai MD, Heping Shen MD, Wenjie Zeng MD
-
Preventing pelvic floor injury at birth Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-17 John O.L. DeLancey MD, Mariana Masteling PhD, James A. Ashton-Miller PhD
-
What modality is optimal for pelvic floor imaging? Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-17 Hans Peter Dietz MD PhD, Ka Lai Shek PhD
-
Maternal cardiovascular profile is altered in the preclinical phase of normotensive early and late intrauterine growth restriction Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-17 Barbara Vasapollo MD PhD, Gian Paolo Novelli MD PhD, Filomena Maellaro MD, Giulia Gagliardi MD, Marcello Pais MD, Marco Silvestrini MD, Francesca Pometti MD, Daniele Farsetti MD, Herbert Valensise MD PhD
The maternal cardiovascular profile of patients who develop late fetal growth restriction has yet to be well characterized, however, a subclinical impairment in maternal hemodynamics and cardiac function may be present before pregnancy and may become evident because of the hemodynamic alterations associated with pregnancy. This study aimed to investigate if maternal hemodynamics and the cardiovascular
-
Discrete placental gene expression signatures accompany diabetic disease classifications during pregnancy Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-17 Enrico R. Barrozo PhD, Diana A. Racusin MD, Michael D. Jochum PhD, Brandon T. Garcia BS, Melissa A. Suter PhD, Melanie Delbeccaro MD, Cynthia Shope MS, Kathleen Antony MD, Kjersti M. Aagaard MD PhD
Gestational diabetes mellitus affects up to 10% of pregnancies and is classified into subtypes gestational diabetes subtype A1 (GDMA1) (managed by lifestyle modifications) and gestational diabetes subtype A2 (GDMA2) (requiring medication). However, whether these subtypes are distinct clinical entities or more reflective of an extended spectrum of normal pregnancy endocrine physiology remains unclear
-
Optimization of the betamethasone and dexamethasone dosing regimen during pregnancy: a combined placenta perfusion and pregnancy physiologically based pharmacokinetic modeling approach Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-17 Joyce E.M. Van Der Heijden MSc, Hedwig Van Hove MSc, Niki M. Van Elst BSc, Petra Van Den Broek BSc, Joris Van Drongelen MD PhD, Hubertina C.J. Scheepers MD PhD, Saskia N. De Wildt MD PhD, Rick Greupink PharmD PhD
Antenatal betamethasone and dexamethasone are prescribed to women who are at high risk of premature birth to prevent neonatal respiratory distress syndrome (RDS). The current treatment regimens, effective to prevent neonatal RDS, may be suboptimal. Recently, concerns have been raised regarding possible adverse long-term neurological outcomes due to high fetal drug exposures. Data from nonhuman primates
-
Very young and advanced maternal age strongly elevates the occurrence of nonchromosomal congenital anomalies: a systematic review and meta-analysis of population-based studies Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-17 Boglárka Pethő MD, Szilárd Váncsa MD PhD, Alex Váradi, Gergely Agócs PharmD PhD, Ákos Mátrai MD, Franciska Zászkaliczky-Iker, Zita Balogh, Ferenc Bánhidy MD PhD, Péter Hegyi MD PhD, Nándor Ács MD PhD
Nonchromosomal congenital anomalies (NCAs) are the most common cause of infant mortality and morbidity. The role of maternal age is well known, although the specifics are not thoroughly elucidated in the literature. To evaluate the role of maternal age in the incidence of NCAs and to pinpoint age groups at higher risk to refine screening protocols. A systematic review and meta-analysis were conducted
-
A prospective safety and feasibility study of a novel device for preterm birth delay and prevention Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-16 Doron Kabiri MD MPH, Vincenzo Berghella MD, Hagai Amsalem MD, Salem Kees MD, Keren Ofir MD, David Shashar MD
-
Effectiveness and safety of a novel, collapsible pessary for management of pelvic organ prolapse Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-16 Kris Strohbehn MD, Paul M. Wadensweiler MD MS, Holly E. Richter PhD MD, Cara L. Grimes MD MAS, Charles R. Rardin MD, Peter L. Rosenblatt MD, Marc R. Toglia MD, Gazala Siddiqui MD, Paul Hanissian MD
Pessaries are an effective treatment for pelvic organ prolapse, yet currently available pessaries can cause discomfort during removal and insertion. An early feasibility trial of an investigational, collapsible pessary previously demonstrated mechanical feasibility during a brief 15-minute office trial. Longer-term, patient-centered safety and efficacy data are needed. This study aimed to assess the
-
Excess use of surgical supplies in minimally invasive benign gynecology surgery: an observational study Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-16 Aya Mohr-Sasson MD, Madison Aycock BA, Noel Higgason BA, Mason Hui MO, Asha Bhalwal MD, Randa Jalloul MD, Mateo G. Leon MD, Olivia Dziadek MD, Alvaro Montealegre MD
Single-use materials and equipment are regularly opened by the surgical team during procedures but left unused, potentially resulting in superfluous costs and excess environmental waste. This study aimed to estimate the excess use of surgical supplies in minimally invasive benign gynecologic surgeries. This is a prospective observational study conducted at a university-affiliated single tertiary medical
-
Maternal mortality in the United States: finally some good news Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-16 Amen Ness MD FACOG
-
Maternal mortality surveillance must go beyond death certificates Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-16 Catherine Deneux-Tharaux MD PhD, Serena Donati MD PhD, International Network of Obstetric Survey System
-
Socioeconomic disadvantage in pregnancy and postpartum risk of cardiovascular disease Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-15 Kartik K. Venkatesh MD PhD, Sadiya S. Khan MD MSc, Janet Catov PhD, Jiqiang Wu MSc, Rebecca McNeil PhD, Philip Greenland MD, Jun Wu PhD, Lisa D. Levine MD, Lynn M. Yee MD MPH, Hyagriv N. Simhan MD, David M. Haas MD, Uma M. Reddy MD MPH, George Saade MD, Robert M. Silver MD, C. Noel Bairey Merz MD, William A. Grobman MD MBA
Pregnancy is an educable and actionable life stage to address social determinants of health (SDOH) and lifelong cardiovascular disease (CVD) prevention. However, the link between a risk score that combines multiple neighborhood-level social determinants in pregnancy and the risk of long-term CVD remains to be evaluated. To examine whether neighborhood-level socioeconomic disadvantage measured by the
-
Association of levonorgestrel-releasing intrauterine device with gynecologic and breast cancers: a national cohort study in Sweden Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-15 Huan Yi MD PhD, Naiqi Zhang MD PhD, Jimiao Huang MM, Ying Zheng MM, Qiu hua Hong BM, Jan Sundquist MD PhD, Kristina Sundquist MD PhD, Xiangqin Zheng MD, Jianguang Ji MD PhD
The levonorgestrel-releasing intrauterine device (LNG-IUD) is widely used for the treatment of menorrhagia, dysmenorrhea, and for contraception. However, the association between the use of LNG-IUD and the risk of site-specific gynecologic and breast cancers remains inconclusive. We aim to address this knowledge gap by investigating whether the use of LNG-IUD is associated with a significant risk of
-
SMFM Consult Series #70: Management of short cervix in individuals without a history of spontaneous preterm birth Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-15 Society for Maternal-Fetal Medicine (SMFM), Joseph Biggio MD MS, SMFM Publications Committee
-
Temporal changes in maternal mortality in the United States Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-15 K.S. Joseph MD PhD, Sarka Lisonkova MD PhD, Sid John MSc, Yasser Sabr MHSc MD, Amélie Boutin MSc PhD, Giulia M. Muraca MPH PhD, Neda Razaz MPH PhD, Wee-Shian Chan MSc MD, Azar Mehrabadi MSc PhD, Justin S. Brandt MD, Enrique F. Schisterman PhD, Cande V. Ananth PhD MPH
-
A framework for explaining maternal mortality increase in the United States: what is missing? Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-15 Saifuddin Ahmed MBBS PhD
-
Why improved surveillance is critical for reducing maternal deaths in the United States: a response to the American College of Obstetricians and Gynecologists Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-09 K.S. Joseph MD PhD, Sarka Lisonkova MD PhD, Amélie Boutin MSc PhD, Giulia M. Muraca MPH PhD, Neda Razaz MPH PhD, Sid John MSc, Yasser Sabr MHSc MD, Wee-Shian Chan MSc MD, Azar Mehrabadi MSc PhD, Justin S. Brandt MD, Enrique F. Schisterman PhD, Cande V. Ananth PhD MPH
-
Intrapartum cardiotocography Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-05-09 Vincenzo Zanardo MD, Gianluca Straface MD